Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bone metastatic carcinoma with EGFR amplification and mutation: A case report and literature review.

Medicine - 20 Jan 2023

Du Hong-Juan, Chen Fang-Fang, Liu Yu, Zhou Yu

Abstract excerpt

RATIONALE: Mutations in the epidermal growth factor receptor (EGFR) gene are highly prevalent in non-small cell lung cancer, while rare in other cancers. Primarily it's hardly present in bone metastases from cancer of unknown primary (BMCUP). Currently, no specific treatment options for bone metastases from unknown primary cancers exist. PATIENT CONCERNS: The right shoulder and back pain of a 72-years-old man had...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aniline Compounds
Share to Bone Neoplasms
Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Neoplasms, Unknown Primary

Share to Protein Kinase Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 36701708
DOI: 10.1097/MD.0000000000032615
PMCID: PMC9857377

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bone metastatic carcinoma with EGFR amplification and mutation: A case report and literature review.PMID 36701708Read ↗

Mutational characteristics of bone metastasis of lung cancer.Semantic proximity Read ↗

Assessing EGFR-mutated NSCLC with bone metastasis: Clinical features and optimal treatment strategy.Semantic proximity Read ↗

Prognosis of different bone metastases patterns in EGFR-mutant advanced lung adenocarcinoma patientsSemantic proximity Read ↗

Rapidly progressive squamous cell lung cancer with MET exon 14 skipping mutation metastasized to atypical bone sites - a case report.Semantic proximity Read ↗

Driver gene mutations and clinical features predict bone metastasis risk in NSCLC: a logistic regression model.Semantic proximity Read ↗

Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical OverviewSemantic proximity Read ↗

Efficacy of 3rd generation TKI in patients with EGFR mutation lung adenocarcinoma with bone metastases: A review of 3 case reports and literature.Semantic proximity Read ↗

Screening of gene mutations associated with bone metastasis in nonsmall cell lung cancer.Semantic proximity Read ↗

Putative lung adenocarcinoma with epidermal growth factor receptor mutation presenting as carcinoma of unknown primary site: A case report.Semantic proximity Read ↗

Clinical Implications of Isolated Bone Failure Without Systemic Disease Progression During EGFR-TKI Treatment.Semantic proximity Read ↗

Carcinoma of unknown primary with a lung cancer profile in mediastinal and/or hilar lymph nodes: EGFR-mutant cases and a literature review of actionable drivers.Semantic proximity Read ↗

Orbital and skull metastases as the initial presentation of lung adenocarcinoma harbouring a MET exon 14 skipping mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.